Alzheimer y priones, paralelismo y estrategias terapéuticas

  1. Gómez Burgueño, L. 1
  2. González Aranda, A M. 1
  3. Gutiérrez Ruiz, A. 1
  4. María Isabel Gegúndez Cámara dir. 1
  1. 1 Universidad de Alcalá
    info

    Universidad de Alcalá

    Alcalá de Henares, España

    ROR https://ror.org/04pmn0e78

Libro:
Enfermedades infecciosas emergentes: experiencia de innovación docente: curso académico 2013/2014
  1. Cuadros González, Juan (coord.)
  2. María Isabel Gegúndez Cámara (coord.)
  3. Consuelo Giménez Pardo (coord.)
  4. Rosario González Palacios (coord.)
  5. Lourdes Lledó García (coord.)
  6. Juan Romanyk Cabrera (coord.)
  7. José Vicente Saz Pérez (coord.)

Editorial: Líneas de Distribución Logística del Papel

ISBN: 978-84-942694-0-0

Ano de publicación: 2014

Páxinas: 11-22

Tipo: Capítulo de libro

DIALNET GOOGLE SCHOLAR

Resumo

Alzheimer disease is the issue of many research works that try to clarify the etiopathogenesis, evolution, diagnosis and treatment of this illness. Nowadays, after years of investigation, it is possible to affirm that the main characters on the pathogenesis of Alzheimer disease are amyloid-β and tau proteins, among other factors. Recent studies maintain that these proteins have certain similarity with prion proteins regarding its behaviour. According to this idea, in this work we explain the main ideas about the parallelism between Alzheimer disease and prionic diseases and also the consideration of Aβ and tau proteins as real prion proteins. In this review we also discuss about the main therapies in the treatment of Alzheimer disease, focussing on the researches based on Aβ and tau proteins as the main therapeutic targets and considering tau protein a very promising field in future researches.

Fonte de datos: Dialnet